Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

30 closest matches · ranked by relevance

N/A N=70 Warfarin and Coronary Calcification Project

Coronary Calcification
Primary: Coronary Calcification (Presence and Degree as Measured by Agatston Score) Attributed to Duration of Warfarin Use in Months After Controlling for Standard Cardiovascular…
Walter Reed Army Medical Center Results Aug 2012 0.0% serious AE View details

Phase 2 N=22 The Effect of Etelcalcetide on CKD-MBD

Chronic Kidney Disease Mineral and Bone Disorder · Renal Osteodystrophy · Vascular Calcification
Primary: Percent Change in PTH Levels — 0; -54.14; -64.04 percentage of change in PTH levels
Thomas Nickolas, MD MS Results Sep 2023 13.6% serious AE View details

Phase 4 N=20 Effect of Atorvastatin on Bone-vascular Axis

Osteoporosis · Hypercholesterolemia
Primary: Relative Change in OPG/RANK/RANKL mRNA Expression in Isolated T Cells and Monocytes — 0.76 relative fold change — p=<0.05
University of Padova Results May 2021 0.0% serious AE View details

Phase 2 N=61 Bone Mass and Strength After Kidney Transplantation

End Stage Renal Disease · Kidney Transplantation · Bone Loss
Primary: Percent Change in Bone Density From Pre to Post-calcitriol Treatment Compared to Placebo as Assessed by Both Standard Methodologies — -0.81; -0.70 percent change
Columbia University Results Mar 2025 0.0% serious AE View details

N/A N=33 RAAS and Arterial Stiffness in SCI

Arterial Stiffness · Renin Angiotensin Aldosterone System · Orthostatic Hypotension
Primary: Pulse Wave Velocity (m/s) — 8.81; 7.36; 5.53 m/s
James J. Peters Veterans Affairs Medical Center Results Feb 2025 0.0% serious AE View details

Phase 4 N=61 Phosphate Lowering in CKD Trial

Chronic Kidney Disease · Cardiovascular Disease
Primary: Brachial Artery Flow-mediated Dilation — 3.13; 3.74; 2.73; 3.09 percent change FMD
VA Office of Research and Development Results Aug 2022 5.3% serious AE View details